Institutional investors purchased a net $4.6 million shares of BIOS during the quarter ended December 2014 and now own 98.84% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Managed Health Care industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GABELLI FUNDS LLC Bought 2.3 Million shares of BioScrip Inc
ARDSLEY ADVISORY PARTNERS Bought 1.6 Million shares of BioScrip Inc
RBC GLOBAL ASSET MANAGEMENT (U.S... Bought 859.5 Thousand shares of BioScrip Inc